Valion Bio VBIO
NASDAQ VBIO
$0.54 +0.02 (+3.85%)
At close: Nov 13, 2026 · 4:00 PM EST

Valion Bio (VBIO) Total Non-Current Liabilities (2020 - 2026)

Updated

Valion Bio's Total Non-Current Liabilities came in at $27.77 million for Q2 2026.

Analysis

Valion Bio (VBIO) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Valion Bio's Total Non-Current Liabilities was $14.52 million.

  • Going back by year, Total Non-Current Liabilities was $272,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 102.65 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 117.60 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 36.05 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 96.04 Bn
10 Valion Bio 73,008.00 -25.39 Mn - 27.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27.56 Mn
Mar 31, 2026 26.64 Mn
Dec 31, 2025 14.47 Mn
Dec 31, 2024 272,000.00
Dec 31, 2020 1.99 Mn
API Access

Valion Bio Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=VBIO&period=max&api_key=YOUR_API_KEY